Project 2 ? Targeted Fungal Ras Signaling for Antimicrobial Therapy Proteins of the important Ras signal transduction pathway have been intensely studied as targets for anticancer therapeutics, but also hold potential in other diseases. We have found central roles for Ras and Ras-processing enzymes in fungal pathogenesis, particularly related to pathogens' capability for high temperature growth. Our evidence suggests that inhibitors of the Ras pathway could serve as novel therapies to treat human fungal diseases. Numerous compounds are in preclinical development and in clinical trials that inhibit Ras, and we propose to start from these known inhibitors to design agents with improved antifungal properties based on our knowledge of the proteins' structures. Our targets are enzymes called prenyltransferases that modify Ras proteins, and we also will explore a second set of Ras-modifying enzymes, the palmitoyltransferases. Both of these proteins are required for proper localization of Ras signaling proteins; without the enzymes' activities, Ras function is lost. We have studied the structure of mammalian prenyltransferases and have helped develop focused prenyltransferase inhibitors. In more recent work, we also have solved the structures of four fungal prenyltransferases, FTase and GGTase, in different pathogenic fungi. Our work has revealed molecular features that are conserved in the fungal enzymes but differ from the mammalian ones. Such fungal-specific features suggest that current inhibitors could be derivatized for enhanced antifungal effect. Our data also indicate that Ras inhibition will be synergistic with therapies directed against fungal calcineurin and trehalose pathways (Projects 1 and 3). In this proposal, we build on and expand our structure-based studies to develop novel synergistic, broad- spectrum antifungals. We propose three Specific Aims: 1) To redirect the large collections of FTase inhibitors (FTIs) developed for cancer chemotherapeutics to antifungal agents using structure-guided approaches. 2) To investigate GGTase as an antifungal drug target, and similarly develop potent inhibitors using structure-guided approaches. 3) To investigate palmitoylation of Ras-family proteins in fungal pathogenesis, and evaluate its potential for therapeutic targeting. Palmitoyltransferases are highly divergent between fungi and mammals, and our proposed genetic and biochemical studies will allow the focused screening and optimization of palmitoylation inhibitors as new antifungals. This Project will utilize all three Cores and interact closely with Projects 1 and 2 of this Program Project in order to accelerate development of novel agents to treat life- threatening fungal infections in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI104533-05
Application #
9709220
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Pianalto, Kaila M; Ost, Kyla S; Brown, Hannah E et al. (2018) Characterization of additional components of the environmental pH-sensing complex in the pathogenic fungus Cryptococcus neoformans. J Biol Chem 293:9995-10008
Brandão, Fabiana; Esher, Shannon K; Ost, Kyla S et al. (2018) HDAC genes play distinct and redundant roles in Cryptococcus neoformans virulence. Sci Rep 8:5209
Lee, Yeonseon; Lee, Kyung-Tae; Lee, Soo Jung et al. (2018) In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates. Antimicrob Agents Chemother 62:
Esher, Shannon K; Zaragoza, Oscar; Alspaugh, James Andrew (2018) Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain. Mem Inst Oswaldo Cruz 113:e180057
Brown, Hannah E; Ost, Kyla S; Esher, Shannon K et al. (2018) Identifying a novel connection between the fungal plasma membrane and pH-sensing. Mol Microbiol 109:474-493
Perfect, John R; Tenor, Jennifer L; Miao, Yi et al. (2017) Trehalose pathway as an antifungal target. Virulence 8:143-149
Kwon-Chung, Kyung J; Bennett, John E; Wickes, Brian L et al. (2017) The Case for Adopting the ""Species Complex"" Nomenclature for the Etiologic Agents of Cryptococcosis. mSphere 2:
Billmyre, R Blake; Heitman, Joseph (2017) Genetic and epigenetic engines of diversity in pathogenic microbes. PLoS Pathog 13:e1006468
Juvvadi, Praveen R; Lee, Soo Chan; Heitman, Joseph et al. (2017) Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach. Virulence 8:186-197
Alspaugh, J Andrew (2017) Targeting protein localization for anti-infective therapy. Virulence 8:1105-1107

Showing the most recent 10 out of 26 publications